Celltrion seeks approval of Avastin biosimilar product in the EU
Celltrion said it has finalized the process of applying for approval of CT-P16, a biosimilar of Avastin (ingredient: bevacizumab), with...
Celltrion said it has finalized the process of applying for approval of CT-P16, a biosimilar of Avastin (ingredient: bevacizumab), with...
Celltrion has declared that it has completed the process of requesting approval of CT-P16, a biosimilar of Avastin (ingredient: bevacizumab),...
Syntellix Claassen CEO: "The biggest and most important success story in the company's history" - Indian CDSCO Grants Approvals for...
HANOVER, Germany, October 7, 2021 / CNW / - india The Central Drugs Standard Control Organization (CDSCO) has granted Syntellix...
Celltrion said it submitted a Marketing Authorization (MAA) application for Regkirona, a treatment for Covid-19, to the European Medicines Agency...
Celltrion said it submitted a Marketing Authorization (MAA) application for Regkirona, a treatment for Covid-19, to the European Medicines Agency...
RESEARCH TRIANGLE PARK – Cambrex Corp., a contract manufacturer of small molecule therapeutics with major facilities in High Point and...
RESEARCH TRIANGLE PARK - Cambrex Corp., a contract manufacturer of small molecule therapies with major facilities in High Point and...